Cronos (TSX:CRON) Stock: $0 or $30?

Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a millionaire-maker stock. The only problem is that it’s also a millionaire-destroyer stock. It all depends on timing. In 2016, shares traded at $0.20. At the start of 2019, they touched $30. In just three years, a $5,000 investment became $750,000. Then the cannabis bear market of 2019 occurred. The industry lost billions of dollars…

Read More

What Aphria’s Move From the NYSE to the NASDAQ Means for Stock Investors

In an unexpected move on Tuesday, one of Canada’s largest marijuana firms Aphria (TSX:APHA)(NYSE:APHA) announced that it is moving its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market effective on Monday, June 8. Aphria’s stock listing migration will take place soon after the firm closes its fiscal year 2020 financial books on…

Read More

Will Altria Buy Out Cronos (TSX:CRON) Stock?

Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…

Read More

Will Cronos (TSX:CRON) Stock Fall Below $5?

Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…

Read More

Cronos Group (TSX:CRON) Stock: 1 Management Decision That Delays Growth in the U.S. Market

Cronos Group (TSX:CRON)(NASDAQ:CRON) finally reported its delayed fourth0quarter and full-year 2019 results on March 30. Much to investors’ disappointment, the company’s quarterly revenue growth in Canada was negative and massive inventory charges drowned spirits. There’s one more piece of information that could warrant a downward revision to the marijuana firm’s potential revenue growth rate. For a start, this was the…

Read More

Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

Why the Cronos Group Stock Price Fell 18.3% in February

The Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) stock price fell 18.3% in February. The market continues to fall and company-specific uncertainty remains high. This is making any prediction for the Cronos Group stock price very uncertain and precarious. Fears of the potential severity of the coronavirus have ruled the market since February. This certainly continues today. As I write this article, I…

Read More

This Small-Cap Pot Stock Beats Canopy to Profitability

When you think about marijuana stocks, you probably think about big names like Canopy Growth and Aurora Cannabis. These companies aren’t turning a profit yet and won’t be profitable any time soon. The first full year of cannabis legalization in Canada has been challenged by scandals, oversupply problems, and lack of visibility in retail. The factors all put downward pressure…

Read More

2 of the Only Pot Stocks Worth Buying Today

Last week, I wrote why I thought Canopy Growth was only worth $15, because its valuation is so astronomically high, it looks like it could take years for the company to grow to the potential the market thinks the company has. At a price to sales of more than 30 times, it’s clear Canopy will need to grow sales at…

Read More

Forget Hexo (TSX:HEXO) Stock! This High-Yield Dividend Stock Is a Sure Winner

Hexo’s stock price has tumbled about 80% from its high. Buying cannabis stocks is like going on a roller-coaster ride with your eyes closed — you don’t know when you’ll fall or be upside down in a loop. For more certain returns, invest in Brookfield Property Partners (TSX:BPY.UN)(NASDAQ:BPY). Price action Hexo investors probably don’t care about fundamentals, because the company is…

Read More